Standard BioTools Inc.
US ˙ NasdaqGS ˙ US34385P1084

SecurityLAB / Standard BioTools Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership704,407 shares
Latest Disclosed Value $ 647,561
Qube Research & Technologies Ltd reports 224.39% increase in ownership of LAB / Standard BioTools Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 704,407 shares of Standard BioTools Inc. (US:LAB) valued at $647,561 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 217,149 shares of Standard BioTools Inc.. This represents a change in shares of 224.39% during the quarter. The current value of the position is $803,024 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F STANDARD BIOTOOLS COM 34385P108 704,407 487,258 224.39 648 133.57 0.0007
2026-02-17 2025-12-31 13F STANDARD BIOTOOLS COM 34385P108 217,149 -65,694 -23.23 278 -24.52 0.0003
2025-11-14 2025-09-30 13F STANDARD BIOTOOLS COM 34385P108 282,843 -158,258 -35.88 368 -30.62 0.0004
2025-08-14 2025-06-30 13F STANDARD BIOTOOLS COM 34385P108 441,101 20,979 4.99 529 16.78 0.0005
2025-05-15 2025-03-31 13F STANDARD BIOTOOLS COM 34385P108 420,122 -71,063 -14.47 454 -47.26 0.0005
2025-02-14 2024-12-31 13F STANDARD BIOTOOLS COM 34385P108 491,185 353,045 255.57 860 222.93 0.0011
2024-11-14 2024-09-30 13F STANDARD BIOTOOLS COM 34385P108 138,140 -1,090,992 -88.76 267 -87.77 0.0004
2024-08-14 2024-06-30 13F STANDARD BIOTOOLS COM 34385P108 1,229,132 -487,835 -28.41 2,176 -53.25 0.0034
2024-05-14 2024-03-31 13F STANDARD BIOTOOLS COM 34385P108 1,716,967 1,716,967 4,653 0.0074
2024-02-13 2023-12-31 13F STANDARD BIOTOOLS COM 34385P108 0 -19,085 -100.00 0 -100.00
2023-11-13 2023-09-30 13F STANDARD BIOTOOLS COM 34385P108 19,085 19,085 55 0.0001
2023-08-14 2023-06-30 13F STANDARD BIOTOOLS COM 34385P108 0 -10,968 -100.00 0 -100.00
2023-05-15 2023-03-31 13F STANDARD BIOTOOLS COM 34385P108 10,968 10,968 21 0.0001
2023-02-14 2022-12-31 13F STANDARD BIOTOOLS COM 34385P108 0 -61,366 -100.00 0 -100.00
2022-11-14 2022-09-30 13F STANDARD BIOTOOLS COM 34385P108 61,366 -6,192 -9.17 68 -37.04 0.0004
2022-08-15 2022-06-30 13F STANDARD BIOTOOLS COM 34385P108 67,558 67,558 108 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.